PR
PSP Research Portfolio holdings
AUM
$141M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$141M
AUM Growth
+$26.9M
(+24%)
Holding
105
Top Buys
| 1 | +$35.6M | |
| 2 | +$6.17M | |
| 3 | +$555K | |
| 4 |
Monte Rosa Therapeutics
GLUE
|
+$535K |
| 5 |
Ardelyx
ARDX
|
+$529K |
Top Sells
| 1 | +$584K | |
| 2 | +$554K | |
| 3 | +$552K | |
| 4 |
BLTE
Belite Bio
BLTE
|
+$551K |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$549K |
Sector Composition
| 1 | Healthcare | 24.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wave Life Sciences
WVE
$1.22B
| – | – |
-31,040
|
|
||
|
ALMS
102
Alumis Inc
ALMS
$2.72B
| – | – |
-43,769
|
|
||
|
UPB
103
Upstream Bio Inc
UPB
$450M
| – | – |
-17,634
|
|
||
|
PVLA
104
Palvella Therapeutics
PVLA
$1.67B
| – | – |
-5,084
|
|
||
|
MAZE
105
Maze Therapeutics
MAZE
$1.44B
| – | – |
-12,672
|
|